AETHLON MEDICAL INC
$6.31
-$0.47 (-6.93%)
$5.80Day Range$6.56
Key Statistics
Market Cap
$4.82M
Shares Outstanding
0.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Nov 6, 1998
Round Lot
100
Locale
US
Trading Data
Day Open
$6.38
Day High
$6.56
Day Low
$5.80
Volume
2.51M
VWAP
$6.19
Prev Close
$6.78
Transactions
--
Acc. Volume
--
About AETHLON MEDICAL INC
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 38419 employees11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA, 92121619-941-0360IPO Nov 6, 1998US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000882291
- Composite FIGI
- BBG000L78XT8
- Share Class FIGI
- BBG001SDDHJ6
- Ticker Root
- AEMD
- SIC Code
- 3841
About AETHLON MEDICAL INC (AEMD) Stock
AETHLON MEDICAL INC (AEMD) closed the 2026-09-18 session at $6.31, down 6.93% versus the previous close (-0.47). The stock opened at $6.38 and traded between $5.80 and $6.56 during that session. Session trading volume was 2.5M shares. The volume-weighted average price (VWAP) is $6.19.
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
AETHLON MEDICAL INC has a market capitalization of $4.8 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. AEMD is listed on the XNAS exchange. The company employs approximately 9 people. AETHLON MEDICAL INC is headquartered in SAN DIEGO, CA. The recorded listing date is 1998-11-06.
On this page you can find market AEMD stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.